Select for export Models of psychedelic drug action: modulation of cortical-subcortical circuits. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/brain/awab406 PubMed 34897383 Copy citation Copy BibTeX Brain 2022-03-31 Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fepid.2022.876706 PubMed 38455323 Copy citation Copy BibTeX Frontiers in Epidemiology 2022-03-22 Davis AK, Arterberry BJ, Xin Y, Agin-Liebes G, Schwarting C, Williams MT. Europe PMC Published psilocybin Observational StudySafety Observational Study More
Select for export The promises and perils of psychedelic pharmacology for psychiatry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41573-022-00421-7 PubMed 35301459 Copy citation Copy BibTeX Unknown journal 2022-03-16 McClure-Begley TD, Roth BL. Europe PMC Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0264927 PubMed 35294453 Copy citation Copy BibTeX PLoS ONE 2022-03-15 Dworatzyk K, Jansen T, Schmidt TT. Europe PMC Published psilocybin AnxietyConsciousnessMystical Experience Observational Study More
Select for export 184. Hallucinogens on TikTok No abstract availability was recorded for this entry. Details DOI 10.1016/j.jadohealth.2022.01.101 Copy citation Copy BibTeX Journal of Adolescent Health 2022-03-10 Amrutha Garimella, Bradley Kerr, Reese H. Hyzer, Megan A. Moreno OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06083-y PubMed 35253070 Copy citation Copy BibTeX Unknown journal 2022-03-06 Sarparast A, Thomas K, Malcolm B, Stauffer CS. Europe PMC Published psilocybin DepressionPTSDPharmacology Randomized Controlled Trial More
Select for export The therapeutic potential of psilocybin: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2047929 PubMed 35225143 Copy citation Copy BibTeX Unknown journal 2022-03-01 van Amsterdam J, van den Brink W. Europe PMC Published psilocybin Clinical TrialRandomized Controlled TrialSystematic Review Randomized Controlled Trial More
Select for export Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06092-x PubMed 35233648 Copy citation Copy BibTeX Unknown journal 2022-03-01 Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. Europe PMC Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073758 PubMed 35253518 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-02-28 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. Europe PMC Published psilocybin Mechanism of ActionPsychological FlexibilityObservational Study Observational Study More
Select for export The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2044096 PubMed 35225726 Copy citation Copy BibTeX Unknown journal 2022-02-27 Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01297-2 PubMed 35217796 Copy citation Copy BibTeX Neuropsychopharmacology 2022-02-24 Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P Europe PMC Published psilocybin AnxietyPharmacologyHealthy Volunteers Clinical Trial More
Select for export Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-06580-2 PubMed 35173246 Copy citation Copy BibTeX Scientific Reports 2022-02-15 Jones GM, Nock MK. Europe PMC Published psilocybin AddictionPersonality ChangeObservational Study Observational Study More
Select for export The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jpainsymman.2022.01.024 PubMed 35157985 Copy citation Copy BibTeX Unknown journal 2022-02-10 Maia LO, Beaussant Y, Garcia ACM. Europe PMC Published psilocybin AnxietySpiritualityRandomized Controlled Trial Randomized Controlled Trial More
Select for export Hallucinogen Use and Misuse in Older Adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.cger.2021.07.007 PubMed 34794703 Copy citation Copy BibTeX Unknown journal 2022-01-31 Redden WM, Paracha SU, Sheheryar Q. Europe PMC Published psilocybin AgingOlder Adults Other More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export [Are psychedelics fast acting antidepressant agents?] Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00115-021-01255-1 PubMed 35103814 Copy citation Copy BibTeX Unknown journal 2022-01-31 Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M Europe PMC Published psilocybin Depression Other More
Select for export Structure-based discovery of nonhallucinogenic psychedelic analogs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1126/science.abl8615 PubMed 35084960 Copy citation Copy BibTeX Science 2022-01-26 Cao D, Yu J, Wang H, Luo Z, Liu X, He L Europe PMC Published psilocybinpsilocin DepressionReceptor PharmacologyAnimal Study Animal Study More
Select for export Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms. No abstract availability was recorded for this entry. Details DOI 10.1080/02791072.2021.1983673 PubMed 35083957 Copy citation Copy BibTeX Unknown journal 2022-01-26 Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. Europe PMC Published psilocybin OCDReview Article Review Article More
Select for export Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06066-z PubMed 35076721 Copy citation Copy BibTeX Psychopharmacology 2022-01-24 Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y Europe PMC Published psilocybin Clinical TrialHealthy Volunteers Clinical Trial More
